Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2010
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2387536C Rate-controlled particles
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/14/2010WO2010054138A2 Modulators of atp-binding cassette transporters
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010053861A2 Biologically active amides
05/14/2010WO2010053732A1 Isoindoline compounds for use in the treatment of cancer
05/14/2010WO2010053471A1 Modulators of atp-binding cassette transporters
05/14/2010WO2010053120A1 Carbamate compound or salt thereof
05/14/2010WO2010052143A1 Radiolabelled inhibitors of the glycine 1 transporter
05/14/2010WO2010051977A1 Substituted disulfonamides as bri-modulators
05/14/2010WO2010017387A3 Lapatinib, salts thereof, processes and intermediates for their preparation
05/14/2010WO2010014883A3 Azacitidine process and polymorphs
05/14/2010CA2742980A1 Modulators of atp-binding cassette transporters
05/14/2010CA2742821A1 Modulators of atp-binding cassette transporters
05/14/2010CA2742741A1 Substituted disulfonamides
05/14/2010CA2742602A1 Gamma secretase modulators
05/14/2010CA2741990A1 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/14/2010CA2741500A1 Carbamate compound or salt thereof
05/14/2010CA2741299A1 Isoindoline compounds for use in the treatment of cancer
05/13/2010US20100121073 Process for the Preparation of (R)-5-(2-Aminoethyl)-1-(6,8-Difluorochroman-3-YL)-1,3-Dihydroimidazole-2-Thione
05/13/2010US20100121062 Slow Release of Organoboronic Acids in Cross-Coupling Reactions
05/13/2010US20100121059 5-PHENOXYALKOXYPSORALENS AND METHODS FOR SELECTIVE INHIBITION OF THE VOLTAGE GATED Kv1.3 POTASSIUM CHANNEL
05/13/2010US20100120856 Derivatives of the Aminated Hydroxyquinoline Class For Treating Cancers
05/13/2010US20100120846 Trpv1 antagonists
05/13/2010US20100120804 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120789 Compound
05/13/2010US20100120783 Melanocortin receptor agonists
05/13/2010US20100120774 (2R,3 S)-3 ((2-chloro-4-pyrimidinyl)amino)-4-(3,5-difluorophenyl)-1 (((4'S)-6'-(2,2-dimethylpropyl)-3', 4'-dihydrospiro[cyclobutane-1,2'-pyrano[2,3-b]pyridin]-4'-yl)amino)-2-butanol, used for the treatment Alzheimer's disease, cognitive deficits and impairment, and schizophrenia
05/13/2010US20100120764 Di-substituted amides for enhancing glutamatergic synaptic responses
05/13/2010US20100120760 Benzofuran-carboxamide derivatives as antiviral agents
05/13/2010US20100120759 Azadecalin glucocorticoid receptor modulators
05/13/2010US20100119503 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
05/13/2010US20100119475 Novel inhibitors of glutaminyl cyclase
05/12/2010EP2184278A1 P2x4 receptor antagonist
05/12/2010EP2183242A2 Pyrimidine derivatives 934
05/12/2010EP2183221A1 New compounds as hsp90 inhibitors
05/12/2010EP2076499B1 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators
05/12/2010EP2066318B1 Oxindole derivatives as anticancer agents
05/12/2010EP1870409B1 Benzimidazole compounds
05/12/2010EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors
05/12/2010CN1867336B 1-aryl-4-substituted piperazines derivatives and pharmaceutical use thereof
05/12/2010CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists
05/12/2010CN1798559B Quinoline-2-one-derivatives for the treatment of airways diseases
05/12/2010CN1671856B Novel physiologically active substances
05/12/2010CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/12/2010CN1537000B Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists
05/12/2010CN101704797A compounds effecting glucokinase
05/12/2010CN101704792A Quinoxalinone derivative with matrix metalloproteinase inhibitory activity and preparation method and application thereof
05/11/2010US7714150 Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
05/11/2010US7714016 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indole-4-one (CBI) with incorporated alkylating domain; in vivo drug-cleavable substrate conjugates that are potent cytotoxins; antiproliferative, anticarcinogenic agent; leukemia; bone marrow and mucosal toxicity; chronic cardiac and neurological toxicity
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7714004 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
05/11/2010US7714001 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
05/11/2010US7713999 Thrombin receptor antagonists
05/11/2010US7713978 N-[6-[cis-3,5-dimethyl-1-piperazinyl]-3-(methyloxy)-2-pyridinyl]-3-fluoro-4-(5-methyl-2-furanyl)benzenesulfonamide; for treating gastrointestinal disorders; agonistic activity at the growth hormone secretagogue (GHS) receptors
05/11/2010US7713964 Methods for treating asthmatic conditions
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2413134C Quinazoline ditosylate salt compounds
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2378603C Benzofuran derivatives
05/11/2010CA2326324C Nitrogen-containing heterocyclic compound
05/11/2010CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010WO2010027848A3 Forms of lapatinib compounds and processes for the preparation thereof
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010US20100113777 INDOLE DERIVATIVES HAVING cPLA2 INHIBITING ACTIVITY AND APPLICATIONS AND PRODUCTION METHODS OF THE SAME
05/06/2010US20100113549 Pyrrolidine compounds
05/06/2010US20100113464 Novel pyridazine derivatives
05/06/2010US20100113444 Prolyl hydroxylase inhibitors
05/06/2010US20100113439 Antifungal agents
05/06/2010US20100113429 Inhibitors of ftsz and uses thereof
05/06/2010US20100113413 MAPK/ERK Kinase Inhibitors
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/05/2010EP2181988A1 Pharmaceutical Compositions based on Crystalline Form I of 5-Azacytidine
05/05/2010EP2181985A1 Antiviral Agent
05/05/2010EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
05/05/2010EP2181098A1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides
05/05/2010EP2057120B1 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines
05/05/2010EP1615914B1 Cgrp receptor antagonists
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010CN1918150B Process for preparing substituted benzopyran compounds
05/05/2010CN1769285B Doxazosin salt with optical activity
05/05/2010CN1666983B Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest contollers and a method for using the same
05/05/2010CN101702905A Functionally selective alpha 2C adrenoreceptor agonists
05/05/2010CN101701006A Phenethanolamine derivatives for treatment of respiratory diseases
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709641 Neurokinin-1, substance P (NK1); serotonin reuptake inhibitors; for treating emesis, depression, anxiety and cough
05/04/2010US7709519 2-(1,3-Dihydro-2H-benzimidazol-2-ylidene)-1-[3-(1,2-dihydroxyethyl)phenyl]-3-(3,4,5-trifluorophenyl)propane-1,3-dione; GnRH receptor antagonism; prostate cancer, breast cancer, endometriosis, uterine leiomyoma, benign prostatic hypertrophy; good availability by oral administration
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709505 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; type 2 diabetes
05/04/2010US7709500 Chemical compounds
05/04/2010US7709491 {8-Fluoro-2-(4'-fluoro-1,1'-biphenyl-4-yl)-3-[3-trifluoromethyl)phenyl]-3,4-dihydro-4-quinazolinyl}acetic acid; have high antiviral activity
05/04/2010US7709487 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 694